Canada markets open in 1 hour 3 minutes

Regencell Bioscience Holdings Limited (RGC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.6500-0.4300 (-8.46%)
At close: 04:00PM EDT
4.5000 0.00 (0.00%)
Pre-Market: 08:10AM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Cash flows from operating activities
Net Income
-5,871
-5,871
-7,446
-1,347
-812.371
Depreciation & amortization
769.687
769.687
604.397
26.456
9.516
Stock based compensation
922.623
922.623
2,758
0
0
Change in working capital
-508.945
-508.945
-1,024
552.978
76.282
Other working capital
-4,990
-4,990
-6,048
-767.311
-844.41
Other non-cash items
-85.4
-85.4
-10.733
-
-
Net cash provided by operating activites
-4,963
-4,963
-5,267
-767.311
-726.573
Cash flows from investing activities
Investments in property, plant and equipment
-27.392
-27.392
-780.876
-
-117.837
Purchases of investments
-10,000
-10,000
-10,000
0
0
Sales/Maturities of investments
10,085
10,085
0
0
-
Net cash used for investing activites
58.978
58.978
-10,781
0
-117.837
Cash flows from financing activities
Common stock issued
0
0
22,673
0
0
Other financing activites
134.913
134.913
164
-172.314
-
Net cash used privided by (used for) financing activities
134.913
134.913
22,406
439.745
988.082
Net change in cash
-4,852
-4,852
6,358
-327.566
143.672
Cash at beginning of period
6,417
6,417
59.413
386.979
243.307
Cash at end of period
1,565
1,565
6,417
59.413
386.979
Free Cash Flow
Operating Cash Flow
-4,963
-4,963
-5,267
-767.311
-726.573
Capital Expenditure
-27.392
-27.392
-780.876
-
-117.837
Free Cash Flow
-4,990
-4,990
-6,048
-767.311
-844.41